Mineralys Therapeutics (NASDAQ:MLYS) used its fourth-quarter and full-year 2025 earnings call to highlight a key regulatory milestone for lorundrostat and to review new clinical and financial updates ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced an enhanced clinical development strategy for IHL-42X, ...

A massive pipe burst out of the road in Osaka, Japan, bringing traffic to a screeching halt. The pipe is 11.5 feet in diameter and rose up to 42 feet above the ground at one point. No one was injured ...

Mineralys had a transformational year in 2025, defined by significant clinical progress and key regulatory milestones,” said Jon Congleton, Chief Executive Officer of Mineralys Therapeutics. “We ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, ...

Overall, while most studies show only modest improvements in sleep quality and duration—and more robust research is still ...

Forecasters predict it will be becoming windier with record-tying warmth; cloudy with heavy t-storms; storms can bring ...

Mineralys Therapeutics Inc. reports fourth-quarter 2025 results Thursday after market close, with analysts expecting a loss of 94 cents per share—wider than the 52-cent loss posted in the third ...

Here's a look at the weather trends in Sandusky County today.

The defense secretary has made clear that Pentagon managers are to encourage workers, including civilians, to volunteer to assist in the administration’s immigration crackdown.

Incannex Healthcare Inc. (Nasdaq: IHXL), ("Incannex" or the "Company") a clinical-stage biopharmaceutical company leading the way ...

Nyxoah to Participate in the Oppenheimer 36 th Annual Healthcare MedTech & Services Conference. Mont-Saint-Guibert, Belgium – March 11, 2026, 10:05 pm CET / 4:05 pm ET ...